NCT06137196 Risk Identification Factors for Pulmonary Function Impairment in AIDS Patients Recovered From Severe Pneumonia
| NCT ID | NCT06137196 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Guangzhou 8th People's Hospital |
| Condition | AIDS |
| Study Type | OBSERVATIONAL |
| Enrollment | 100 participants |
| Start Date | 2023-11-01 |
| Primary Completion | 2026-11-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 100 participants in total. It began in 2023-11-01 with a primary completion date of 2026-11-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Screening for risk factors related to lung function impairment in patients who have recovered from AIDS with severe pneumonia, to provide clinical evidence for early identification and intervention of lung function damage in this population.
Eligibility Criteria
Inclusion Criteria: 1. Confirmed HIV infection; 2. Progression to the AIDS stage: CD4+ count \<200 cells/µL and/or occurrence of opportunistic infections associated with AIDS; 3. Age between 18 to 65 years; 4. Meet the diagnostic criteria for severe pneumonia, with reference to the 2021 treatment guidelines for community-acquired pneumonia developed by the American Thoracic Society (ATS) and the Infectious Diseases Society of America (IDSA). Exclusion Criteria: 1. Concurrent central nervous system lesions, severe liver disease, or cirrhosis; 2. Concurrent AIDS-related or non-related tumors; 3. Women who are pregnant or breastfeeding; 4. Presence of serious underlying diseases such as heart, lung, liver, kidney, etc.; 5. Alcohol abuse or drug use; 6. The researcher believes that the overall condition of the subject affects the evaluation and completion of the trial
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06137196 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying AIDS. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06137196 currently recruiting?
Yes, NCT06137196 is actively recruiting participants. Contact the research team at llheliza@126.com for enrollment information.
Where is the NCT06137196 trial being conducted?
This trial is being conducted at Guangzhou, China.
Who is sponsoring the NCT06137196 clinical trial?
NCT06137196 is sponsored by Guangzhou 8th People's Hospital. The trial plans to enroll 100 participants.